In This Week’s Issue:
1. PIPC Submits Comments to Senators Addressing Barriers to Price and Information Transparency, click here to read the letter.
2. The Hill: Limiting Patient Choice Is The Wrong Way To Address High Drug Prices, click here to read the op-ed.
3. Health Affairs: Patient-Centered Formularies — Steps In The Right Direction, But Challenges Remain, click here to read the blog.
4. Request for Nominations: PCORI Board of Governors, click here to apply
5. IFPA White Paper: The ICER Myth, click here to read the white paper
6. Webinar: CMS Quality Measures — How They are used and How You Can Be involved, see details below.
7. Upcoming Events and Webinars, see details below.
8. Medical Journal Articles, see details below.
9. AHRQ Effective Program Updates, see details below.
1. PIPC Submits Comments to Senators Addressing Barriers to Price and Information Transparency, click here to read the letter.
2. The Hill: Limiting Patient Choice Is The Wrong Way To Address High Drug Prices, click here to read the op-ed.
3. Health Affairs: Patient-Centered Formularies — Steps In The Right Direction, But Challenges Remain, click here to read the blog.
4. Request for Nominations: PCORI Board of Governors, click here to apply
5. IFPA White Paper: The ICER Myth, click here to read the white paper
6. Webinar: CMS Quality Measures — How They are used and How You Can Be involved, see details below.
7. Upcoming Events and Webinars, see details below.
8. Medical Journal Articles, see details below.
9. AHRQ Effective Program Updates, see details below.
1. PIPC Submits Comments to Senators Addressing Barriers to Price and Information Transparency
PIPC has submitted comments to a group of bipartisan senators who requested information on barriers to price and information transparency in health care. “Empowering patients is the missing step to improving quality of healthcare and lowering healthcare costs. Innovation and patient- centered outcomes research makes care tailored to individual patients possible based on our increased understanding of the differential impact of treatments on diverse patients. With increased availability of information about treatments, patients will be empowered to be self- advocates for higher quality healthcare.” Click here to read the letter.
2. The Hill: Limiting Patient Choice Is The Wrong Way To Address High Drug Prices
In an op-ed for The Hill, David Daikh and Ralph Sacco argue for more patient choice in drug pricing. “Further limiting therapy options based on a drug’s price, as the administration’s proposal seeks to do, is a dangerous experiment that targets the wrong part of the drug delivery chain and threatens our patients’ health and wellbeing. It also does nothing to address the high initial prices and year-over-year increases to the cost of obtaining these drugs that providers and patients alike have had to manage. If the administration truly wants to lower drug prices, it should promote policies that expand – not limit – competition and choice.” Click here to read the op-ed.
3. Health Affairs: Patient-Centered Formularies — Steps In The Right Direction, But Challenges Remain
In Health Affairs, Jason Shafrin and Mark Linthicum note that patient perspectives on value matter when developing formularies. “A patient-centered formulary must both capture value from patients’ perspectives (especially by including outcomes and treatment attributes of importance to patients) and accommodate patient diversity. Although there are challenges on both fronts, paths forward do exist—Arrow’s impossibility theorem notwithstanding. While there are many ways to make formularies more patient-centered, consider how the following three initiatives could help formulary design better meet the needs of a diverse patient population.” Click here to read the blog.
4. Request for Nominations: PCORI Board of Governors
PIPC Chairman Tony Coelho urges patients, people with disabilities and other stakeholders to take advantage of this great opportunity to nominate candidates for the PCORI Board of Governors! The GAO is accepting nominations for the PCORI Board of Governors. “GAO is accepting nominations in the following categories required in statute: A physician, a nurse, a representative of patients and health care consumers, a representative of private payers, a representative of a state or a federal health program or agency, and a representative of pharmaceutical, device, or diagnostic manufacturers or developers. Nominations should be sent to the email or mailing address listed below. Acknowledgement of submissions will be provided within a week of submission.” Click here to apply. Deadline: May 4, 2018.
5. IFPA White Paper: The ICER Myth
The Institute for Patient Access (IFPA) has published a white paper outlining the flaws in ICER’s value-based analyses. “Amid widespread debate about pharmaceutical prices, ICER has made a name for itself by generating the unicorn of health care economic analysis: the price at which an innovative drug provides value. The group has come under scrutiny for its methodology and calculations. Critics have also made an issue of ICER’s funding, some of which comes directly from health insurers or from nonprofit foundations supported by health insurers. But perhaps the organization’s biggest drawback is its suggestion that the value of life-altering drugs for individual patients can be lumped into a “one-size-fits-all” calculation. ICER’s “value-based price” is a fallacy, and a dangerous one. In the hands of health plans, these prices can become negotiation tools.” Click here to read the white paper
6. Webinar: CMS Quality Measures — How They are used and How You Can Be involved
The Centers for Medicare and Medicaid (CMS) is hosting a series of webinars that will provide education on quality measures. “We are offering an Introduction to CMS Quality Measures webinar series available to the public. On April 26th, from 1:00 - 2:00 PM, Eastern Time, CMS will host the first of a two-part series that covers an introduction to quality measures, overview of the measure development process, how the public can get involved, and the new Meaningful Measures initiative. If you are unable to attend during that time, the same session will be offered again on May 2nd, from 4:00 - 5:00 PM, Eastern Time. CMS is looking for your feedback and participation in the quality measurement community, so please join us during the webinar to learn what we are doing and how you can be a part of the process!” Click here to register for April 26; here for May 2.
7. Upcoming Events and Webinars
Precision Health, Big Data, and Evidence-Based Medicine - Contradictions or Companions?
April 19, 2018
Click here for details.
Advisory Panel on Patient Engagement Spring 2018 Meeting
April 19-20, 2018
Click here for details.
PCORI Online: Cycle 1 2018 Application Submission Webinar
April 24, 2018
Click here for details.
2018 Patient Centered Outcomes Research Symposium
April 25, 2018
Click here for details.
PCORI Board of Governors Meeting
April 30, 2018
Click here for details
Advisory Panel on Clinical Trials Spring 2018 Meeting
May 7, 2018
Click here for details
NPC @ ISPOR 23rd Annual International Meeting
May 19-23, 2018
Click here for details
DIA 2018 Global Annual Meeting
June 24-28, 2018
Click here for details.
8. Medical Journal Articles
Patient and Family Advisory Councils (PFACs): Identifying Challenges and Solutions to Support Engagement in Research, click here to view.
Missing Data in Trial-Based Cost-Effectiveness Analysis: An Incomplete Journey, click here to view.
Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients with Atrial Fibrillation, click here to view.
Patient-Centered Recruitment and Retention for a Randomized Controlled Study, click here to view.
Pharmaceutical Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing, click here to view.
Frequency and Magnitude of Co-Payments Exceeding Prescription Drug Costs, click here to view.
Factors Contributing to Higher Health Care Spending in the United States Compared With Other High-Income Countries, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Increasing Uptake of Comparative Effectiveness and Patient-Centered Outcomes Research Among Stakeholders: Insights from Conference Discussion, click here to view.
Comparative Effectiveness and Patient-Centered Outcomes Research: Enhancing Uptake and Use by Patients, Clinicians and Payers, click here to view.
Comparative Effectiveness Research Requires Competitive Effectiveness, click here to view.
What Parents of Children With Complex Medical Conditions Want Their Child’s Physicians to Understand, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols, click here to view.
Ensuring the Patient Voice in Quality: An Educational Program for Patient Groups and Advocates, click here to view.
Patient-Reported Outcomes: Design with the End in Mind, click here to view.
9. AHRQ Effective Program Updates
Role of Immunotherapy in the Treatment of Asthma, click here to view.
Library of Common Data Definitions: Atrial Fibrillation, click here to view.
Library of Common Data Definitions: Asthma, click here to view.
Patient or Participant Generated Registries, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Prioritization and Selection of Harms for Inclusion in Systematic Reviews, click here to view.
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents, click here to view.
A Framework for Conceptualizing Evidence Needs of Health Systems, click here to view.
Nonsurgical Treatments for Urinary Incontinence in Adult Women: A Systematic Review Update, click here to view.
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Management of Insomnia Disorder - Consumer and Clinician Summaries, click here to view
Harms of First-Line Depression Treatment in Older Adults, click here to view.
Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence - Clinician Summary, click here to view.
PIPC has submitted comments to a group of bipartisan senators who requested information on barriers to price and information transparency in health care. “Empowering patients is the missing step to improving quality of healthcare and lowering healthcare costs. Innovation and patient- centered outcomes research makes care tailored to individual patients possible based on our increased understanding of the differential impact of treatments on diverse patients. With increased availability of information about treatments, patients will be empowered to be self- advocates for higher quality healthcare.” Click here to read the letter.
2. The Hill: Limiting Patient Choice Is The Wrong Way To Address High Drug Prices
In an op-ed for The Hill, David Daikh and Ralph Sacco argue for more patient choice in drug pricing. “Further limiting therapy options based on a drug’s price, as the administration’s proposal seeks to do, is a dangerous experiment that targets the wrong part of the drug delivery chain and threatens our patients’ health and wellbeing. It also does nothing to address the high initial prices and year-over-year increases to the cost of obtaining these drugs that providers and patients alike have had to manage. If the administration truly wants to lower drug prices, it should promote policies that expand – not limit – competition and choice.” Click here to read the op-ed.
3. Health Affairs: Patient-Centered Formularies — Steps In The Right Direction, But Challenges Remain
In Health Affairs, Jason Shafrin and Mark Linthicum note that patient perspectives on value matter when developing formularies. “A patient-centered formulary must both capture value from patients’ perspectives (especially by including outcomes and treatment attributes of importance to patients) and accommodate patient diversity. Although there are challenges on both fronts, paths forward do exist—Arrow’s impossibility theorem notwithstanding. While there are many ways to make formularies more patient-centered, consider how the following three initiatives could help formulary design better meet the needs of a diverse patient population.” Click here to read the blog.
4. Request for Nominations: PCORI Board of Governors
PIPC Chairman Tony Coelho urges patients, people with disabilities and other stakeholders to take advantage of this great opportunity to nominate candidates for the PCORI Board of Governors! The GAO is accepting nominations for the PCORI Board of Governors. “GAO is accepting nominations in the following categories required in statute: A physician, a nurse, a representative of patients and health care consumers, a representative of private payers, a representative of a state or a federal health program or agency, and a representative of pharmaceutical, device, or diagnostic manufacturers or developers. Nominations should be sent to the email or mailing address listed below. Acknowledgement of submissions will be provided within a week of submission.” Click here to apply. Deadline: May 4, 2018.
5. IFPA White Paper: The ICER Myth
The Institute for Patient Access (IFPA) has published a white paper outlining the flaws in ICER’s value-based analyses. “Amid widespread debate about pharmaceutical prices, ICER has made a name for itself by generating the unicorn of health care economic analysis: the price at which an innovative drug provides value. The group has come under scrutiny for its methodology and calculations. Critics have also made an issue of ICER’s funding, some of which comes directly from health insurers or from nonprofit foundations supported by health insurers. But perhaps the organization’s biggest drawback is its suggestion that the value of life-altering drugs for individual patients can be lumped into a “one-size-fits-all” calculation. ICER’s “value-based price” is a fallacy, and a dangerous one. In the hands of health plans, these prices can become negotiation tools.” Click here to read the white paper
6. Webinar: CMS Quality Measures — How They are used and How You Can Be involved
The Centers for Medicare and Medicaid (CMS) is hosting a series of webinars that will provide education on quality measures. “We are offering an Introduction to CMS Quality Measures webinar series available to the public. On April 26th, from 1:00 - 2:00 PM, Eastern Time, CMS will host the first of a two-part series that covers an introduction to quality measures, overview of the measure development process, how the public can get involved, and the new Meaningful Measures initiative. If you are unable to attend during that time, the same session will be offered again on May 2nd, from 4:00 - 5:00 PM, Eastern Time. CMS is looking for your feedback and participation in the quality measurement community, so please join us during the webinar to learn what we are doing and how you can be a part of the process!” Click here to register for April 26; here for May 2.
7. Upcoming Events and Webinars
Precision Health, Big Data, and Evidence-Based Medicine - Contradictions or Companions?
April 19, 2018
Click here for details.
Advisory Panel on Patient Engagement Spring 2018 Meeting
April 19-20, 2018
Click here for details.
PCORI Online: Cycle 1 2018 Application Submission Webinar
April 24, 2018
Click here for details.
2018 Patient Centered Outcomes Research Symposium
April 25, 2018
Click here for details.
PCORI Board of Governors Meeting
April 30, 2018
Click here for details
Advisory Panel on Clinical Trials Spring 2018 Meeting
May 7, 2018
Click here for details
NPC @ ISPOR 23rd Annual International Meeting
May 19-23, 2018
Click here for details
DIA 2018 Global Annual Meeting
June 24-28, 2018
Click here for details.
8. Medical Journal Articles
Patient and Family Advisory Councils (PFACs): Identifying Challenges and Solutions to Support Engagement in Research, click here to view.
Missing Data in Trial-Based Cost-Effectiveness Analysis: An Incomplete Journey, click here to view.
Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients with Atrial Fibrillation, click here to view.
Patient-Centered Recruitment and Retention for a Randomized Controlled Study, click here to view.
Pharmaceutical Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing, click here to view.
Frequency and Magnitude of Co-Payments Exceeding Prescription Drug Costs, click here to view.
Factors Contributing to Higher Health Care Spending in the United States Compared With Other High-Income Countries, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Increasing Uptake of Comparative Effectiveness and Patient-Centered Outcomes Research Among Stakeholders: Insights from Conference Discussion, click here to view.
Comparative Effectiveness and Patient-Centered Outcomes Research: Enhancing Uptake and Use by Patients, Clinicians and Payers, click here to view.
Comparative Effectiveness Research Requires Competitive Effectiveness, click here to view.
What Parents of Children With Complex Medical Conditions Want Their Child’s Physicians to Understand, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols, click here to view.
Ensuring the Patient Voice in Quality: An Educational Program for Patient Groups and Advocates, click here to view.
Patient-Reported Outcomes: Design with the End in Mind, click here to view.
9. AHRQ Effective Program Updates
Role of Immunotherapy in the Treatment of Asthma, click here to view.
Library of Common Data Definitions: Atrial Fibrillation, click here to view.
Library of Common Data Definitions: Asthma, click here to view.
Patient or Participant Generated Registries, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Prioritization and Selection of Harms for Inclusion in Systematic Reviews, click here to view.
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents, click here to view.
A Framework for Conceptualizing Evidence Needs of Health Systems, click here to view.
Nonsurgical Treatments for Urinary Incontinence in Adult Women: A Systematic Review Update, click here to view.
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Management of Insomnia Disorder - Consumer and Clinician Summaries, click here to view
Harms of First-Line Depression Treatment in Older Adults, click here to view.
Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence - Clinician Summary, click here to view.
